Approximately $1.2 billion investment expected to create about 490 high-skill, high-wage manufacturing jobs in South Carolina’s Upstate Blacksburg facility will serve as a cornerstone of USA Rare Earth’s domestic magnet manufacturing footprint and advance the Company’s integrated mine-to-magnet value chain Investment strengthens U.S. capacity to produce critical rare earth metals and magnets for defense, aerospace, semiconductors, energy and other advanced industriesBLACKSBURG, S.C., Sept. 09, 2026 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (“USA Rare Earth,” “USAR” or the “Company”), a rare earth, critical minerals and advanced materials company, today broke ground on its new rare earth metal and magnet manufacturing facility in Blacksburg, South Carolina, marking a major step in the Company’s effort to build a...

Includes Monday Night Hockey and over 100 additional matchups The best sports entertainment experience now includes more games than ever before TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) — Rogers Communications today announced the addition of exclusive Sportsnet+ content to TV packages at no additional cost, including over 150 NHL games. “Rogers Xfinity brings sports fans more NHL games than ever before and the best seat in the house,” said Bret Leech, President, Residential. “By adding content exclusive to Sportsnet+ into our TV packages, we’re bringing more value to Rogers Xfinity customers and making it easier for them to seamlessly catch all the action with our world-class platform.” Starting September 29, Rogers is adding three new digital channels with the exclusive content to Rogers Xfinity TV packages that have Sportsnet,...

Oslo, September 9, 2026: Zelluna ASA held its extraordinary general meeting today September 9, 2026. All the matters on the agenda were approved. The minutes from the meeting are enclosed and available at the company’s website. For further information, please see www.zelluna.com or contact: Anders Tuv, Chairman of the BoardEmail: anders@clairon.noPhone: +47 982 06 826 Namir Hassan, Chief Executive OfficerEmail: namir.hassan@zelluna.com Phone: +44 7720 687608 Geir Christian Melen, Chief Financial OfficerEmail: geir.christian.melen@zelluna.comPhone: +47 913 02 965  AttachmentMinutes of the Extraordinary General Meeting in Zelluna ASA 2026

Eric Adams to join TurboGen’s Advisory Board PETAH TIKVA, ISRAEL, Sept. 09, 2026 (GLOBE NEWSWIRE) — TurboGen Ltd. (“TurboGen” or the “Company”), a developer and manufacturer of multi-fuel microturbines for distributed power generation, today announced that it has entered into a strategic business consulting and development agreement (the “Agreement”) with a strategic group including Former New York City Mayor Eric Adams (the “Strategic Group”). This strategic collaboration is designed to support TurboGen’s next phase of growth in the United States and internationally by expanding the Company’s access to strategic customers and partners, strengthening its business development capabilities, and creating new commercial opportunities for its distributed power-generation technology, addressing a critical need for resiliency and decentralized...

DENVER, Sept. 09, 2026 (GLOBE NEWSWIRE) — (247marketnews.com) — NeOnc Technologies Holdings (NASDAQ:NTHI) is entering a potentially important new phase with fresh institutional capital, encouraging Phase 2a data and a string of open-market insider purchases. The company announced a $15 million registered direct offering priced at-the-market under Nasdaq rules, involving new and existing healthcare-focused institutional investors. The deal includes 3.57 million shares, or pre-funded warrants in lieu of shares, plus warrants covering another 3.57 million shares at a $4.20 exercise price. Closing is expected tomorrow, subject to customary conditions. The financing structure itself deserves attention. An at-the-market-priced registered direct can be considerably more attractive to existing shareholders than the deeply discounted...

Nasdaq Copenhagen        Euronext DublinLondon Stock Exchange        Other stakeholders Date        9 September 2026 Financial calendar 2027 for Ringkjøbing Landbobank The financial calendar for the upcoming year is as follows:3 February 2027: Annual Report 2026 3 March 2027: Annual general meeting 28 April 2027: Quarterly report, 1st quarter 2027 11 August 2027: Interim report 2027 27 October 2027: Quarterly report, 1st-3rd quarters 2027Annual general meeting 3 March 2027 Items to be included on the agenda at the bank’s AGM must be submitted in writing to the bank no later than on 19 January 2027.Yours faithfully Ringkjøbing Landbobank  John FiskerCEOAttachmentFinancial calendar 2027

GRAND CAYMAN, Cayman Islands, Sept. 09, 2026 (GLOBE NEWSWIRE) — Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“Oxbridge” or the “Company”) today announced that members of its executive team will attend the H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14-16, 2026, at the Lotte New York Palace Hotel in New York City. The conference brings together public companies, institutional investors, family offices and other capital markets participants for one-on-one meetings, presentations and networking. Oxbridge will attend to engage with existing and prospective investors and discuss the Company’s evolution as a multi-platform company spanning AI infrastructure, tokenized real-world assets and reinsurance. Through AI GridWorks, Oxbridge is expanding into AI infrastructure...

ORLANDO, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO, Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on September 16th. The Summit brings together biotechnology executives, investors, and industry leaders for an evening of thought leadership and networking at Nasdaq MarketSite in New York. About AVERSA™ Abuse-Deterrent Transdermal Technology Nutriband’s AVERSA™ abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. The AVERSA™ abuse-deterrent technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that...